<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="117539">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01744769</url>
  </required_header>
  <id_info>
    <org_study_id>KUH1010379</org_study_id>
    <nct_id>NCT01744769</nct_id>
  </id_info>
  <brief_title>Effects of Thyroid Hormone Withdrawal on Metabolic Parameters During Radioactive Iodine Therapy in Thyroid Cancer</brief_title>
  <official_title>Effects of Thyroid Hormone Withdrawal on Metabolic and Cardiovascular Parameters During Radioactive Iodine Therapy in Differentiated Thyroid Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konkuk University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konkuk University Medical Center</source>
  <oversight_info>
    <authority>South Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. The incidence of differentiated thyroid cancer is increasing in Korea. A significant
           number of them experience severe hypothyroidism in preparation for radioactive iodine
           (RAI) therapy after total thyroidectomy.

        2. Because the function of thyroid hormone is closely linked with lipid and glucose
           metabolism, overt hypothyroidism after thyroid hormone withdrawal during RAI therapy
           may induce the changes of metabolic parameters.

        3. We investigate the effects of thyroid hormone withdrawal on metabolic and
           cardiovascular parameters during radioactive iodine therapy in differentiated thyroid
           cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Study design measurement of various parameters during hypothyroid state (before 1
           month, the day and after 1 month of RAI therapy)

        2. Measurements

             1. Measurement of metabolic and cardiovascular parameters

                  -  glucose profiles : HbA1c, fasting glucose level

                  -  lipid profiles : free fatty acid, total, LDL-, HDL-, cholesterol,
                     triglyceride

                  -  adipocytokines : retinol binding protein(RBP)

                  -  4, leptin, resistin, adiponectin

                  -  markers of endothelial and cardiac function : high-sensitivity C-reactive
                     protein(hsCRP), homocystein, B-type natriuretic peptide(BNP)

                  -  bone turnover markers : CTX, bone ALP

             2. Scoring of symptoms and signs of hypothyroidism (Zulewski score)

                  -  symptoms

                  -  physical signs
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">May 2013</completion_date>
  <primary_completion_date type="Anticipated">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Changes of metabolic parameters</measure>
    <time_frame>Before 1month of radioiodine therapy, Day of radioiodine therapy, After 1 month of radioiodine therapy</time_frame>
    <safety_issue>No</safety_issue>
    <description>glucose profiles : HbA1c, fasting glucose level
lipid profiles : free fatty acid, total, LDL-, HDL-, cholesterol, triglyceride
adipocytokines : retinol binding protein(RBP)4, leptin, resistin, adiponectin
markers of endothelial and cardiac function : high-sensitivity C-reactive - protein(hsCRP), homocystein, B-type natriuretic peptide(BNP)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes of bone turnover markers</measure>
    <time_frame>Before 1month of radioiodine therapy, Day of radioiodine therapy, After 1 month of radioiodine terapy</time_frame>
    <safety_issue>No</safety_issue>
    <description>bone formation marker: bone ALP
bone resorption marker: CTX</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Hypothyroidism</condition>
  <arm_group>
    <arm_group_label>Hypothyroidism for RAI</arm_group_label>
    <description>The group of patients who experience hypothyroidism after thyroid hormone withdrawal for radioactive iodine(RAI) therapy</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        the patients who experience severe hypothyroidism after thyroid hormone withdrawal for
        radioiodine therapy in differentiated thyroid cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  radioiodine therapy after total thyroidectomy in differentiated thyroid cancer

          -  age over 18

        Exclusion Criteria:

          -  kidney failure, liver failure, heart failure

          -  infection

          -  inflammation

          -  autoimmune disease

          -  other chronic disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suk Kyeong Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Konkuk University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Suk Kyeong Kim, MD, PhD</last_name>
    <phone>82-2-2030-7531</phone>
    <email>20120137@kuh.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jee Hyun An, MD, PhD</last_name>
    <phone>82-10-9089-4655</phone>
    <email>jeehyunan@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Konkuk University Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>143-729</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jee Hyun An</last_name>
      <phone>82-10-9089-4655</phone>
      <email>jeehyunan@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Suk Kyoung Kim, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jee Hyun An, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ki Ho Song, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dong Lim Kim, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <lastchanged_date>December 6, 2012</lastchanged_date>
  <firstreceived_date>December 5, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konkuk University Medical Center</investigator_affiliation>
    <investigator_full_name>Suk Kyeong Kim</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>thyroid cancer</keyword>
  <keyword>hypothyroidism</keyword>
  <keyword>metabolic parameters</keyword>
  <keyword>Hypothyroidism after levothyroxine withdrawal</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Thyroid Neoplasms</mesh_term>
    <mesh_term>Hypothyroidism</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Iodine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
